{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,25]],"date-time":"2025-11-25T14:01:08Z","timestamp":1764079268102,"version":"3.37.3"},"reference-count":84,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T00:00:00Z","timestamp":1501545600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","sempedneurjnl.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Pediatric Neurology"],"published-print":{"date-parts":[[2017,8]]},"DOI":"10.1016\/j.spen.2017.08.011","type":"journal-article","created":{"date-parts":[[2017,9,2]],"date-time":"2017-09-02T04:46:58Z","timestamp":1504327618000},"page":"180-188","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Cancer and Autoimmunity: Paraneoplastic Neurological Disorders Associated With Neuroblastic Tumors"],"prefix":"10.1016","volume":"24","author":[{"given":"Wendy G.","family":"Mitchell","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Franz","family":"Blaes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.spen.2017.08.011_bib1","doi-asserted-by":"crossref","first-page":"3201","DOI":"10.1002\/eji.201445191","article-title":"Conflicting consequences of immunity to cancer versus autoimmunity to neurons: insights from paraneoplastic disease","volume":"44","author":"Steinman","year":"2014","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.spen.2017.08.011_bib2","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1097\/CCO.0000000000000222","article-title":"Update on neurological paraneoplastic syndromes","volume":"27","author":"Hoftberger","year":"2015","journal-title":"Curr Opin Oncol"},{"key":"10.1016\/j.spen.2017.08.011_bib3","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1097\/WCO.0000000000000442","article-title":"Widening the spectrum of inflammatory disorders of the central nervous system","volume":"30","author":"Graus","year":"2017","journal-title":"Curr Opin Neurol"},{"key":"10.1016\/j.spen.2017.08.011_bib4","series-title":"Swaiman's Pediatric Neurology: Principles and Practice, 6e. In: Swaiman KF, Ashwal S, Ferriero DM, Schor NF, Finkel RS, Gropman AL, Perle PL, Shevell MI (Eds.), Chapter 118, Part XV. Immune Mediated Disorders of the Nervous System","first-page":"925","article-title":"Paraneoplastic syndromes","author":"Boire","year":"2018"},{"issue":"1","key":"10.1016\/j.spen.2017.08.011_bib5","doi-asserted-by":"crossref","first-page":"e179","DOI":"10.1542\/peds.2006-3324","article-title":"Rapid-onset obesity with hypothalamic hypoventilation, and autonomic dysregulation presenting in childhood","volume":"120","author":"Ize-Ludow","year":"2007","journal-title":"Pediatrics"},{"key":"10.1016\/j.spen.2017.08.011_bib6","doi-asserted-by":"crossref","DOI":"10.1136\/bcr.02.2010.2706","article-title":"Rapid-onset obesity with hyporthalamic syfunction, hypobentilation and autonomic dystegulation (ROHHAD): A case with additional features and review of the literature","author":"Chew","year":"2011","journal-title":"BMJ Case Rep"},{"issue":"4","key":"10.1016\/j.spen.2017.08.011_bib7","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1097\/MOP.0000000000000118","article-title":"Rapid-onset obesity with hypothalamic dysfunction, hypoventilation, and autonomic dysregulation: Review and update","volume":"26","author":"Patwari","year":"2014","journal-title":"Curr Opin Pediatr"},{"key":"10.1016\/j.spen.2017.08.011_bib8","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1177\/1043454204272560","article-title":"Neuroepidemiologic trends in 105 cases of pediatric opsoclonus-myoclonus syndrome","volume":"22","author":"ate","year":"2005","journal-title":"J Pediatr Oncol Nurs"},{"key":"10.1016\/j.spen.2017.08.011_bib9","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1177\/088307389400900320","article-title":"Idiopathic hypothalamic dysfunction with dilated unresponsive pupils: Report of two cases","volume":"9","author":"North","year":"1994","journal-title":"J Child Neurol"},{"key":"10.1016\/j.spen.2017.08.011_bib10","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1177\/088307389400900320","article-title":"Idiopathic hypothalamic dysfunction with dilated unresponsive pupils: Report of two cases","volume":"9","author":"Nunn","year":"1994","journal-title":"J Child Neurol"},{"key":"10.1016\/j.spen.2017.08.011_bib11","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1016\/S0140-6736(95)91899-X","article-title":"Idiopathic hypothalamic dysfunction: A paraneoplastic syndrome?","volume":"346","author":"Ouvrier","year":"1995","journal-title":"Lancet"},{"key":"10.1016\/j.spen.2017.08.011_bib12","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1002\/mpo.10157","article-title":"Hypothalamic dysfunction associated with neuroblastoma: Evidence for a new paraneoplastic syndrome?","volume":"40","author":"Sirvent","year":"2003","journal-title":"Med Pediatr Oncol"},{"issue":"4","key":"10.1016\/j.spen.2017.08.011_bib13","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1203\/PDR.0b013e318229474d","article-title":"Rapid-onset obesity with hypothalamic dysfunction, hypoventilation, and autonomic dystregulation: Analysis of hypothalamic and autonomic candidate genes","volume":"70","author":"Rand","year":"2011","journal-title":"Pediatr Res"},{"issue":"4","key":"10.1016\/j.spen.2017.08.011_bib14","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1007\/s13312-016-0849-5","article-title":"ROHHAD syndrome: the girl who forgets to breath","volume":"53","author":"Sanklecha","year":"2016","journal-title":"Indian Pediatr"},{"issue":"12","key":"10.1016\/j.spen.2017.08.011_bib15","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1002\/ppul.23164","article-title":"Rapid-onset obesity with hypothalamic dysfunction, hypoventilation, and autonomic dysregulation (ROHHAD): Response to ventilatory changes","volume":"50","author":"Carroll","year":"2015","journal-title":"Pediatr Pulmonol"},{"issue":"10","key":"10.1016\/j.spen.2017.08.011_bib16","doi-asserted-by":"crossref","first-page":"3971","DOI":"10.1210\/jc.2008-0238","article-title":"Endocrine manifestations of the rapid onset obesity with hypoventilation, hypothalamic, autonomic dysregulation, and neural tumor syndrome in childhood","volume":"93","author":"Bougn\u00e8res","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.spen.2017.08.011_bib17","doi-asserted-by":"crossref","unstructured":"Jacobson LA, Rane S, McREynolds LG: Improved behavior and neurospychological function in children with ROHHAD after high-dose cyclophosphamide. Pediatrics 138:e20151080, 2016. http:\/\/dx.doi.org\/10.1542\/peds.2015-1080","DOI":"10.1542\/peds.2015-1080"},{"issue":"3","key":"10.1016\/j.spen.2017.08.011_bib18","first-page":"237","article-title":"Nocturnal anxiety in a youth with rapid-onset obesity, hypothalamuc dysfunction, hyperventilation, and autonomic dysreguation (ROHHAD)","volume":"22","author":"Grudnikoff","year":"2013","journal-title":"J Can Acad Child Adolesc Psychiatry"},{"key":"10.1016\/j.spen.2017.08.011_bib19","doi-asserted-by":"crossref","first-page":"e12","DOI":"10.4158\/EP12140.CR","article-title":"A case of rapid-onset obesity with hypothalamic dysfunction, hypoventilation, autonomic dysregulation, and neural crest tumor: ROHHADNET syndrome","volume":"19","author":"Abaci","year":"2013","journal-title":"Endocr Pract"},{"issue":"1","key":"10.1016\/j.spen.2017.08.011_bib20","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1111\/j.1460-9592.2012.03924.x","article-title":"Anesthetic considerations for rapid-onset obesity, hypoventilation, hypothalamic dysfunction, and autonomic dysfunction (ROHHAD) syndrome in children","volume":"23","author":"Chandrakantan","year":"2013","journal-title":"Paediatr Anaesth"},{"key":"10.1016\/j.spen.2017.08.011_bib21","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.pediatrneurol.2014.11.019","article-title":"Rapid-onset obesity with hypothalamic dysfunction, hypoventilation, and autonomic dysregulation (ROHHAD) syndrome may have a hypothalamus-periaqueductal gray localization","volume":"52","author":"Chow","year":"2015","journal-title":"Pediatr Neurol"},{"issue":"5","key":"10.1016\/j.spen.2017.08.011_bib22","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1210\/jc.2014-4215","article-title":"Whole exome sequencing identifies RAl1 mutation in a morbidly obese child diagnosed with ROHHAD syndrome","volume":"100","author":"Thaker","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.spen.2017.08.011_bib23","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1515\/jpem-2015-0129","article-title":"Rapid-onset obesity with hyothalamic dysfunction, hypoventilation, and autonomic dysregulation syndrome and celiac disease in a 13-year-old girl: further evidence for autoimmunity?","volume":"29","author":"Cemeroglu","year":"2016","journal-title":"J Pediatr Endocrinol Metab"},{"key":"10.1016\/j.spen.2017.08.011_bib24","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1002\/pbc.23131","article-title":"Opsoclonus-myoclonus and anti-Hu positive limbic encephalitis in a patient with neuroblastoma","volume":"58","author":"Morales La Madrid","year":"2012","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.spen.2017.08.011_bib25","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/0887-8994(94)90127-9","article-title":"Anti-Hu antibody in a neuroblastoma-associated paraneoplastic syndrome","volume":"10","author":"Fisher","year":"1994","journal-title":"Pediatr Neurol"},{"issue":"Suppl 1","key":"10.1016\/j.spen.2017.08.011_bib26","doi-asserted-by":"crossref","first-page":"S99","DOI":"10.1007\/BF03545599","article-title":"Paraneoplastic encephalomyelitis in a child with neuroblastoma","volume":"25","author":"Meyer","year":"1995","journal-title":"Pediatr Radiol"},{"key":"10.1016\/j.spen.2017.08.011_bib27","article-title":"Paraneoplastic gastro-intestinal anti-Hu syndrome in neuroblastoma","author":"Drukker","year":"2016","journal-title":"Pediatrics"},{"key":"10.1016\/j.spen.2017.08.011_bib28","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1002\/1097-0142(19950101)75:1<99::AID-CNCR2820750117>3.0.CO;2-I","article-title":"Major histocompatibility proteins, anti-Hu antibodies, and paraneoplastic encephalomyelitis in neuroblastoma and small cell lung cancer","volume":"75","author":"Dalmau","year":"1995","journal-title":"Cancer"},{"issue":"1","key":"10.1016\/j.spen.2017.08.011_bib29","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1002\/ana.410380117","article-title":"Hu antigens: reactivity with Hu antibodies, tumor expression, and major immunogenic sites","volume":"38","author":"Manley","year":"1995","journal-title":"Ann Neurol"},{"issue":"1-2","key":"10.1016\/j.spen.2017.08.011_bib30","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.jneuroim.2008.01.007","article-title":"B and T cell imbalance in CSF of patients with Hu-antibody asociated PNS","volume":"195","author":"de Graaf","year":"2008","journal-title":"J Neuroimmunol"},{"issue":"1-2","key":"10.1016\/j.spen.2017.08.011_bib31","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.jneuroim.2013.02.006","article-title":"Elevated numbers of regulatory T cells, central memory T cells and class-switched B cells in cerebropsinal fluid of patients with anti-Hu antibody associated paraneoplastic syndromes","volume":"258","author":"de Jonsgste","year":"2013","journal-title":"J Neuroimmunol"},{"issue":"1","key":"10.1016\/j.spen.2017.08.011_bib32","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1093\/neuonc\/nou126","article-title":"A prospective open-label study of sirolimus for the treatment of anti-Hu associated paraneoplastic neurological syndromes","volume":"17","author":"de Jongste","year":"2015","journal-title":"Neuro Oncol"},{"key":"10.1016\/j.spen.2017.08.011_bib33","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1007\/s00467-005-2004-8","article-title":"Therapeutic total plasma exchange in a child with neuroblastoma-related anti-Hu syndrome","volume":"20","author":"van Vuurden","year":"2005","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.spen.2017.08.011_bib34","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1136\/jnnp.25.3.271","article-title":"Myoclonic encephalopathy of infants","volume":"25","author":"Kinsbourne","year":"1962","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.spen.2017.08.011_bib35","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1056\/NEJM196808292790907","article-title":"Opsoclonus and occult neuroblastoma","volume":"279","author":"Solomon","year":"1968","journal-title":"N Engl J Med"},{"key":"10.1016\/j.spen.2017.08.011_bib36","first-page":"119","article-title":"Myoclonic encephalopathy of infants or \u201cdancing eyes syndrome.\u201d Report of 7 cases with long-term follow-up and review of the literature (cases with and without neuroblastoma)","volume":"34","author":"Boltshauser","year":"1979","journal-title":"Helv Paediatr Acta"},{"key":"10.1016\/j.spen.2017.08.011_bib37","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1002\/1097-0142(197602)37:2<846::AID-CNCR2820370233>3.0.CO;2-L","article-title":"Favorable prognosis for survival in children with coincident opso-myoclonus and neuroblastoma","volume":"37","author":"Altman","year":"1976","journal-title":"Cancer"},{"key":"10.1016\/j.spen.2017.08.011_bib38","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/0022-3468(73)90400-4","article-title":"Neuroblastoma and myoclonic encephalopathy: Two cases and a review of the literature","volume":"8","author":"Senelick","year":"1973","journal-title":"J Pediatr Surg"},{"key":"10.1016\/j.spen.2017.08.011_bib39","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/S0022-3468(89)80291-X","article-title":"Clinical outcome in children with acute cerebellar encephalopathy and neuroblastoma","volume":"24","author":"Telander","year":"1989","journal-title":"J Pediatr Surg"},{"key":"10.1016\/j.spen.2017.08.011_bib40","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1002\/mpo.1138","article-title":"Opsoclonus-myoclonus-ataxia syndrome in neuroblastoma: clinical outcome and antineuronal antibodies\u2014A report from the Children's Cancer Group Study","volume":"36","author":"Rudnick","year":"2001","journal-title":"Med Pediatr Oncol"},{"key":"10.1016\/j.spen.2017.08.011_bib41","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1177\/0883073812450318","article-title":"Acute cerebellar ataxia, acute cerebellitis, and opsoclonus-myoclonus syndrome","volume":"27","author":"Desai","year":"2012","journal-title":"J Child Neurol"},{"key":"10.1016\/j.spen.2017.08.011_bib42","doi-asserted-by":"crossref","first-page":"781","DOI":"10.2214\/ajr.146.4.781","article-title":"CT scanning in patients with opsomyoclonus: Importance of nonenhanced scan","volume":"146","author":"Donaldson","year":"1986","journal-title":"AJR Am J Roentgenol"},{"key":"10.1016\/j.spen.2017.08.011_bib43","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1002\/mds.20125","article-title":"CSF B-cell expansion in opsoclonus-myoclonus syndrome: A biomarker of disease activity","volume":"19","author":"Pranzatelli","year":"2004","journal-title":"Mov Disord"},{"key":"10.1016\/j.spen.2017.08.011_bib44","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1177\/1043454204272560","article-title":"Neuroepidemiologic trends in 105 US cases of pediatric opsoclonus-myoclonus syndrome","volume":"22","author":"Tate","year":"2005","journal-title":"J Pediatr Oncol Nurs"},{"key":"10.1016\/j.spen.2017.08.011_bib45","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1055\/s-0029-1237723","article-title":"Long-term follow-up of neuroblastoma-associated opsoclonus-myoclonus-ataxia syndrome","volume":"40","author":"De Grandis","year":"2009","journal-title":"Neuropediatrics"},{"key":"10.1016\/j.spen.2017.08.011_bib46","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1542\/peds.109.1.86","article-title":"Opsoclonus-ataxia caused by childhood neuroblastoma: Developmental and neurologic sequelae","volume":"109","author":"Mitchell","year":"2002","journal-title":"Pediatrics"},{"key":"10.1016\/j.spen.2017.08.011_bib47","doi-asserted-by":"crossref","unstructured":"Catsman-Berrevoets CAF, van Hemsbergen MLC, Van Noesel MM, et al. Persistent improvement of neurologic status and quality of life in children with opsoclonus-myoclonus syndrome at long term. Poster presented at European Pediatric Neurology Society, United Kingdom, 2009","DOI":"10.1016\/S1090-3798(09)70312-5"},{"key":"10.1016\/j.spen.2017.08.011_bib48","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1055\/s-2006-955931","article-title":"High dose pulsatile dexamethasone therapy in children with opsoclonus-myoclonus syndrome","volume":"37","author":"Rostasy","year":"2006","journal-title":"Neuropediatrics"},{"key":"10.1016\/j.spen.2017.08.011_bib49","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.braindev.2011.04.005","article-title":"Another promising treatment option for neuroblastoma-associated opsoclonus-myoclonus syndrome by oral high-dose dexamethasone pulse: Lymphocyte markers as disease activity","volume":"34","author":"Oguma","year":"2012","journal-title":"Brain Dev"},{"key":"10.1016\/j.spen.2017.08.011_bib50","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1177\/0883073808324217","article-title":"Insights on chronic-relapsing opsoclonus-myoclonus from a pilot study of mycophenolate mofetil","volume":"24","author":"Pranzatelli","year":"2009","journal-title":"J Child Neurol"},{"key":"10.1016\/j.spen.2017.08.011_bib51","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/j.cyto.2010.12.004","article-title":"Chemokine\/cytokine profiling after rituximab: Reciprocal expression of BCA-1\/CXCL13 and BAFF in childhood OMS","volume":"53","author":"Pranzatelli","year":"2011","journal-title":"Cytokine"},{"key":"10.1016\/j.spen.2017.08.011_bib52","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1177\/088307389000500217","article-title":"Opsoclonus-ataxia due to childhood neural crest tumors: A chronic neurologic syndrome","volume":"5","author":"Mitchell","year":"1990","journal-title":"J Child Neurol"},{"key":"10.1016\/j.spen.2017.08.011_bib53","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1177\/0883073814549581","article-title":"Effect of increased immunosuppression on developmental outcome of opsoclonus myoclonus syndrome (OMS)","volume":"30","author":"Mitchell","year":"2015","journal-title":"J Child Neurol"},{"key":"10.1016\/j.spen.2017.08.011_bib54","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.pediatrneurol.2017.03.011","article-title":"Opsoclonus-myoclonus syndrome: A new era of improved prognosis?","volume":"72","author":"Galstyan","year":"2017","journal-title":"Pediatr Neurol"},{"key":"10.1016\/j.spen.2017.08.011_bib55","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1080\/14737175.2016.1176914","article-title":"Childhood opsoclonus-myoclonus syndrome: Diagnosis and treatment","volume":"16","author":"Blaes","year":"2016","journal-title":"Expert Rev Neurother"},{"key":"10.1016\/j.spen.2017.08.011_bib56","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00002826-199619010-00001","article-title":"The immunopharmacology of the opsoclonus-myoclonus syndrome","volume":"19","author":"Pranzatelli","year":"1996","journal-title":"Clin Neuropharmacol"},{"key":"10.1016\/j.spen.2017.08.011_bib57","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1055\/s-2007-985906","article-title":"Increased prevalence of autoimmune disorders and autoantibodies in parents of children with opsoclonus-myoclonus syndrome (OMS)","volume":"38","author":"Krasenbrink","year":"2007","journal-title":"Neuropediatrics"},{"key":"10.1016\/j.spen.2017.08.011_bib58","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.jneuroim.2008.05.033","article-title":"Autoantibodies in childhood opsoclonus-myoclonus syndrome","volume":"201-202","author":"Blaes","year":"2008","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.spen.2017.08.011_bib59","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1177\/08830738040190120201","article-title":"Evidence of cellular immune activation in children with opsoclonus-myoclonus: Cerebrospinal fluid neopterin","volume":"19","author":"Pranzatelli","year":"2004","journal-title":"J Child Neurol"},{"key":"10.1016\/j.spen.2017.08.011_bib60","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.jneuroim.2013.11.004","article-title":"CSF neurofilament light chain is elevated in OMS (decreasing with immunotherapy) and other pediatric neuroinflammatory disorders","volume":"266","author":"Pranzatelli","year":"2014","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.spen.2017.08.011_bib61","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.jneuroim.2009.03.006","article-title":"Elevated B-cell activating factor BAFF, but not APRIL, correlates with CSF cerebellar autoantibodies in pediatric opsoclonus-myoclonus syndrome","volume":"210","author":"Fuhlhuber","year":"2009","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.spen.2017.08.011_bib62","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.cyto.2008.06.001","article-title":"Therapeutic down-regulation of central and peripheral B-cell-activating factor (BAFF) production in pediatric opsoclonus-myoclonus syndrome","volume":"44","author":"Pranzatelli","year":"2008","journal-title":"Cytokine"},{"key":"10.1016\/j.spen.2017.08.011_bib63","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.jneuroim.2011.12.014","article-title":"Key role of CXCL13\/CXCR5 axis for cerebrospinal fluid B cell recruitment in pediatric OMS","volume":"243","author":"Pranzatelli","year":"2012","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.spen.2017.08.011_bib64","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.cyto.2013.05.020","article-title":"CCR7 signaling in pediatric opsoclonus-myoclonus: Upregulated serum CCL21 expression is steroid-responsive","volume":"64","author":"Pranzatelli","year":"2013","journal-title":"Cytokine"},{"key":"10.1016\/j.spen.2017.08.011_bib65","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1007\/s10875-013-9867-4","article-title":"CCR4 agonists CCL22 and CCL17 are elevated in pediatric OMS sera: Rapid and selective down-regulation of CCL22 by ACTH or corticosteroids","volume":"33","author":"Pranzatelli","year":"2013","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.spen.2017.08.011_bib66","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1097\/00043426-200411000-00006","article-title":"Immunophenotype of blood lymphocytes in neuroblastoma-associated opsoclonus-myoclonus","volume":"26","author":"Pranzatelli","year":"2004","journal-title":"J Pediatr Hematol Oncol"},{"key":"10.1016\/j.spen.2017.08.011_bib67","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1212\/WNL.62.9.1526","article-title":"B- and T-cell markers in opsoclonus-myoclonus syndrome: Immunophenotyping of CSF lymphocytes","volume":"62","author":"Pranzatelli","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.spen.2017.08.011_bib68","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/0165-5728(87)90088-9","article-title":"Anti-neurofilament protein antibodies in opsoclonus-myoclonus","volume":"15","author":"Noetzel","year":"1987","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.spen.2017.08.011_bib69","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1016\/S0022-3476(97)70272-5","article-title":"Serum autoantibodies in childhood opsoclonus-myoclonus syndrome: An analysis of antigenic targets in neural tissues","volume":"130","author":"Connolly","year":"1997","journal-title":"J Pediatr"},{"key":"10.1016\/j.spen.2017.08.011_bib70","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1002\/ana.20539","article-title":"Surface-binding autoantibodies to cerebellar neurons in opsoclonus syndrome","volume":"58","author":"Blaes","year":"2005","journal-title":"Ann Neurol"},{"key":"10.1016\/j.spen.2017.08.011_bib71","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1196\/annals.1423.027","article-title":"New autoantibodies in pediatric opsoclonus myoclonus syndrome","volume":"1110","author":"Kirsten","year":"2007","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.spen.2017.08.011_bib72","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1136\/jnnp.2005.078105","article-title":"Post-streptococcal opsoclonus-myoclonus syndrome associated with anti-neuroleukin antibodies","volume":"77","author":"Candler","year":"2006","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.spen.2017.08.011_bib73","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1002\/ana.10462","article-title":"Autoantigen diversity in the opsoclonus-myoclonus syndrome","volume":"53","author":"Bataller","year":"2003","journal-title":"Ann Neurol"},{"key":"10.1016\/j.spen.2017.08.011_bib74","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.jneuroim.2005.08.018","article-title":"Functional characterisation of autoantibodies from patients with pediatric opsoclonus-myoclonus-syndrome","volume":"170","author":"Korfei","year":"2005","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.spen.2017.08.011_bib75","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.jneuroim.2015.10.022","article-title":"Autoantibody-mediated cytotoxicity in paediatric opsoclonus-myoclonus syndrome is dependent on ERK-1\/2 phophorylation","volume":"289","author":"Fuhlhuber","year":"2015","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.spen.2017.08.011_bib76","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.semcancer.2011.09.012","article-title":"Immunology and immunotherapy of neuroblastoma","volume":"21","author":"Seeger","year":"2011","journal-title":"Semin Cancer Biol"},{"key":"10.1016\/j.spen.2017.08.011_bib77","doi-asserted-by":"crossref","first-page":"35770","DOI":"10.18632\/oncotarget.5657","article-title":"Natural killer cells facilitate PRAME-specific T-cell reactivity against neuroblastoma","volume":"6","author":"Spel","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.spen.2017.08.011_bib78","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1002\/mpo.1139","article-title":"Opsoclonus-myoclonus-ataxia syndrome in neuroblastoma: histopathologic features-a report from the Children\u2019s Cancer Group","volume":"36","author":"Cooper","year":"2001","journal-title":"Med Pediatr Oncol"},{"key":"10.1016\/j.spen.2017.08.011_bib79","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1007\/s00428-002-0747-1","article-title":"Neuroblastic tumors associated with opsoclonus-myoclonus syndrome: Histological, immunohistochemical and molecular features of 15 Italian cases","volume":"442","author":"Gambini","year":"2003","journal-title":"Virchows Arch"},{"key":"10.1016\/j.spen.2017.08.011_bib80","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1189\/jlb.0213106","article-title":"Role of BAFF in opsoclonus-myoclonus syndrome, a bridge between cancer and autoimmunity","volume":"94","author":"Raffaghello","year":"2013","journal-title":"J Leukoc Biol"},{"key":"10.1016\/j.spen.2017.08.011_bib81","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/S0929-693X(00)80129-3","article-title":"Opsoclonus-myoclonus syndrome associated with non-metastatic neuroblastoma. Long-term survival. Study of the French Society of Pediatric Oncologists","volume":"7","author":"Plantaz","year":"2000","journal-title":"Arch Pediatr"},{"key":"10.1016\/j.spen.2017.08.011_bib82","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1002\/1097-0142(19880815)62:4<723::AID-CNCR2820620413>3.0.CO;2-U","article-title":"Single copies of the N-myc oncogene in neuroblastomas from children presenting with the syndrome of opsoclonus-myoclonus","volume":"62","author":"Cohn","year":"1988","journal-title":"Cancer"},{"key":"10.1016\/j.spen.2017.08.011_bib83","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1084\/jem.20031462","article-title":"Natural killer T cells infiltrate neuroblastomas expressing the chemokine CCL2","volume":"199","author":"Metelitsa","year":"2004","journal-title":"J Exp Med"},{"key":"10.1016\/j.spen.2017.08.011_bib84","doi-asserted-by":"crossref","first-page":"2702","DOI":"10.1172\/JCI30751","article-title":"Oncogene MYCN regulates localization of NKT cells to the site of disease in neuroblastoma","volume":"117","author":"Song","year":"2007","journal-title":"J Clin Invest"}],"container-title":["Seminars in Pediatric Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1071909117301079?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1071909117301079?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,8,2]],"date-time":"2022-08-02T03:21:52Z","timestamp":1659410512000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1071909117301079"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8]]},"references-count":84,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2017,8]]}},"alternative-id":["S1071909117301079"],"URL":"https:\/\/doi.org\/10.1016\/j.spen.2017.08.011","relation":{},"ISSN":["1071-9091"],"issn-type":[{"type":"print","value":"1071-9091"}],"subject":[],"published":{"date-parts":[[2017,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cancer and Autoimmunity: Paraneoplastic Neurological Disorders Associated With Neuroblastic Tumors","name":"articletitle","label":"Article Title"},{"value":"Seminars in Pediatric Neurology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.spen.2017.08.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}